MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Strategies for Implementation of a Quality Improvement Registry for DBS in Parkinson’s Disease

    J. Jimenez-Shahed, P. D'Haese, J. Kirk, M. York, A. Berg, L. Shih, J. Schwalb, J. Mcinerney (Houston, TX, USA)

    Objective: To describe the implementation of a quality improvement (QI) patient registry for deep brain stimulation (DBS) in Parkinson's disease (PD). Background: QI projects are…
  • 2019 International Congress

    DBS in Parkinson’s disease: Experience from Egypt

    A. Mansour, Z. Fayed (Cairo, Egypt)

    Objective: To highlight our Experience in DBS for Parkinson’s in Egypt, to our knowledge we are the first team for DBS in Egypt, and so…
  • 2019 International Congress

    Surgery‐related 30-day morbidity of deep brain stimulation in a large cohort of 600 patients

    J. Runge, A. Saryyeva, C. Blahak, C. Schrader, H. Bäzner, HH. Capelle, M. Abdallat, M. Wolf, TM. Kinfe, JK. Krauss (Hannover, Germany)

    Objective: In this retrospective study we analyzed the surgery‐ and hardware‐related morbidity of deep brain stimulation within 30 days after surgery. Background: 600 functional stereotactic…
  • 2019 International Congress

    Changing for a rechargeable neurostimulator in Parkinson’s disease patients: safety and feasibility

    T. Wirth, C. Laurencin, J. Berthiller, A. Brindzeu, E. Simon, G. Polo, P. Mertens, E. Broussolle, T. Danaila, S. Thobois (Strasbourg, France)

    Objective: This study aimed to determine the feasibility and safety of the replacement of non-rechargeable implanted pulse generator (IPG) by rechargeable ones. Background: DBS of…
  • 2019 International Congress

    Single Centre Experience of PEG Feeding in Parkinson’s Disease

    H. Fairclough, H. Bashir, R. Beekman, M. Lee, E. Johns, C. Mcdonald (Gateshead, United Kingdom)

    Objective: To determine factors influencing mortality in patients who receive percutaneous endoscopic gastrostomy (PEG) in Parkinson ’s disease (PD). Background: PD is a progressive neurological…
  • 2019 International Congress

    Ipsilesional arm levitation after left hemispheric stroke: a case series

    M. Klarendic, N. Prezelj, R. Berlot, V. Zgonc, M. Kojovic (Ljubljana, Slovenia)

    Objective: We present three patients with left hemispheric stroke and spontaneous ipsilesional arm levitation (IAL), a phenomenon not hitherto described. Background: Spontaneous arm levitation (AL) is…
  • 2019 International Congress

    Neurology Residents Versus a Mobile Medical Application in deducing differential diagnoses in Movement Disorders: A multi-center, cross-sectional, observational study

    V. Vishnu, P. Vinny, R. Rajan, V. Goyal, P. Srivastava, V. Lal, P. Sylaja, L. Narasimhan, S. Dwivedi, P. Nair, D. Ramachandran, A. Gupta (New Delhi, India)

    Objective: To test the hypothesis that the differentials generated by the  Mobile Medical Application  are more clinically relevant and complete to the ones derived by…
  • 2019 International Congress

    Impairment of Neurological Ontogenesis in Children with Austism Spectrum Disorders

    V. Kozyavkin, T. Voloshyn (Truskavets, Ukraine)

    Objective: To assess level of involvement of neurological impairment in children with Autism Spectrum Disorders (ASD). Background: Autism Spectrum Disorders are not singly related to…
  • 2019 International Congress

    Non motor symptoms Parkinson’s disease

    N. Bagdanova, Z. Zuleiha (Kazan, Russian Federation)

    Objective: 1.To identify the representation and prevalence of non-motor symptoms of PD in the premotor and early motor stages Background: During the period 2016-2018 104 people were…
  • 2019 International Congress

    Construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)

    KR. Chaudhuri, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, A. Schrag, P. Martinez-Martin (London, United Kingdom)

    Objective: To analyze the construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS). Background: The MDS-NMS is a new instrument that…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley